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ABSTRACT 
Both Amyotrophic Lateral Sclerosis (ALS) patients and astronauts in spaceflight suffer from 
muscle atrophy. Previous research suggests that the enzyme acid sphingomyelinase (ASM) may 
be involved in the pathogenesis of ALS, but it is not known if ASM influences muscle atrophy in 
microgravity. In this study, C. elegans were exposed to microgravity conditions on the 
International Space Station (ISS) within the confines of a Fluid Mixing Enclosure (FME). Return 
of the FME yielded 72,050 live nematodes, the first demonstration of C. elegans survival of 
space travel in an FME. After the nematodes returned to Earth, in much larger numbers than seen 
in previous FME experiments, the size and ASM expression levels in experimental worms were 
compared to control Earth-bound worms. C. elegans that returned from the ISS were larger in 
both length and cross-sectional area than the control worms, and they exhibited decreased 
expression of ASM-1 and ASM-2 proteins. Further research must be conducted to elucidate the 
role of ASM in muscle atrophy, as there were many limitations to this study. Understanding the 
role of ASM in muscle atrophy may lead to the discovery of novel targets for treatment of both 
ALS and muscle atrophy in microgravity. This study was a student led initiative and undertaken 
as a project within the Student Spaceflight Experiment Program (SSEP), under the auspices of 
the National Center for Earth and Space Science Education and the Arthur C Clarke Institute for 
Space Education.  
INTRODUCTION 
Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by a loss 
of motor neurons and, as a result, skeletal muscle atrophy (van Es et al., 2017). Muscle atrophy is 
the decrease in muscle size/mass that results from loss of contractile and structural proteins and 
muscle cells (Brooks and Myburgh, 2014; Fanzani et al., 2012). The progressive motor neuron 
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loss, and denervation induced-primary muscle dysfunction in ALS culminates in paralysis and 
death (van Es et al., 2017; Loeffler et al 2016). Unfortunately, there are currently no effective 
curative treatments or therapeutic strategies for ALS (van Es et al., 2017). Muscle atrophy is 
prevalent across many chronic diseases (Powers et al. (A), 2016), in individuals subjected to 
prolonged bed-rest and immobility (Brooks and Myburgh, 2014), and in astronauts in spaceflight 
(Fitts et al., 2010). In fact, the neuromuscular system is seen as one of the most heavily impacted 
physiological systems in microgravity (Fitts et al., 2001). Muscle atrophy in microgravity has 
been previously linked to a lack of exercise opportunities (Fitts et al., 2010). However, the use of 
resistive exercise countermeasures programmes by astronauts was only able to partially mitigate 
muscle atrophy in microgravity (Fitts et al., 2010; Tanaka et al., 2017). Given the engineering 
challenge to generate artificial gravity in spaceflight, and the inability of resistance exercise to 
prevent atrophy in microgravity, it is essential to continue to delineate the molecular mechanisms 
underpinning muscle loss in space to enable the development of effective interventions to 
preserve and/or restore muscle mass. We were provided an opportunity by the Student 
Spaceflight Experiment Program (SSEP), a space education program aimed at students from 
elementary school to college level administered through NCESSE’s Arthur C. Clarke Institute 
for Space Education, to conduct an experiment on the International Space Station (ISS). We 
decided to investigate the underlying causes of muscle atrophy in microgravity. This research 
may bring us one step closer to developing an effective treatment for muscle wasting and 
weakness  in both astronauts during spaceflight and in those with chronic disease such as ALS. 
Oxidative stress contributes to the development of skeletal muscle atrophy in both chronic 
disease states and inactivity via a myriad cellular signaling networks (Cutler et al., 2002; Powers 
et al.(B), 2016.), Microgravity has been shown to induce oxidative stress (Takahashi et al., 
2017). Sphingomyelin and ceramide accumulation have been linked to both ALS pathogenesis 
and to oxidative stress (Cutler et al., 2002). Furthermore, there is evidence of increased gene 
expression of acid sphingomyelinase (ASM), an enzyme that catalyzes the hydrolysis of 
sphingomyelin to phosphorylcholine and ceramide, in the SODG86R ALS mouse model 
(Henriques et al., 2018), which could contribute further to ceramide accumulation. ASM levels 
are elevated, and activity is increased  in the presence of oxidative stress, infection and 
inflammation (Kornhuber et al., 2015). However, ASM also releases ceramide, which in itself 
induces oxidative stress (Jana et al., 2009). These data together suggest that ASM dysregulation 
may be involved in the pathology of ALS and muscle wasting of spaceflight 
We therefore undertook a study to determine ASM levels in a small, yet complex organism 
with a neuromuscular system: Caenorhabditis elegans (C. elegans) (Szewczyk and Jacobson, 
2005). C. elegans is a small nematode that is very similar genetically to humans (WormAtlas, 
2006). In fact, almost 40% of its genes are closely related to those of humans and C. elegans is 
recognized as a suitable model for studying human disease in space (Adenle et al., 2009). C. 
elegans has three ASMs, but this study focuses on ASM-1 and ASM-2. Both ASM-1 and ASM-2 
are 30% homologous to the human ASM (Lin et al., 1998).  
In this study, C. elegans were sent to the ISS to experience microgravity, while control C. 
elegans remained on Earth. We hypothesized that the worms on the ISS would develop muscle 
atrophy and experience increased ASM levels compared to the ground experiment. Atrophy 
extent was determined by morphometric analyses. ASM expression was determined by 
measuring protein levels. Overall, this study aimed to elucidate the role of ASM in muscle 
atrophy in microgravity, which may have additional implications for diseases characterized by 
muscle disuse and wasting. 
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MATERIALS AND METHODS 
Housing and Feeding of C. elegans  
This experiment was conducted within a Type 3 Fluids Mixing Enclosure (FME) system 
(NanoRacks, Houston, TX, USA), designed for space research. FMEs have been used for all 
previous SSEP experiments (Warren et al., 2013). The FME is a flexible silicone tube, divided 
into three 2.8 mL compartments by plastic clamps (Figure 1). Sterilization of the FME minilab 
was achieved  by autoclaving the tube, at 121°C for 20 minutes, spraying the caps and clamps 
with 70% ethanol followed by exposure to ultraviolet (UV) light for 1 hour.  
 
Figure 1: Type 3 FME Mini-Lab. The FME is 17 cm in length with a total volume of 8.4 
mL divided into three 2.8 mL compartments. Volume 1 and 3 contained 2.4 mL of CeMM 
and Volume 2 contained 2.4 mL of CeMM housing 5,000 C. elegans. 
 
 C. elegans maintenance medium (CeMM, a gift from Dr L. Garcia) was used as the food 
source and growth medium in the FME. CeMM was used instead of E. coli, the traditional food 
source for C. elegans (Avery and You., 2012), because E. coli is viewed as toxic risk on the ISS. 
2.4 mL of CeMM was added to each of Chambers 1, 2 and 3. In Chamber 2 of the FME, 5,000 
C. elegans were added to the 2.4 mL of CeMM.. This compartmentalization ensured that the 
amount of food available to the worms could be controlled and rationed by unclamping and 
reclamping the tube. The worms loaded were at mixed stages of development, which helped 
ensure their survival under the unpredictable conditions during pre-flight storage and shipment 
(Szewczyk, 2005). The FME systems were assembled at room temperature in the ground 
laboratory, and sealed on both ends with plastic caps, twist ties, and gel, and placed into a 
polyethylene bag to prevent contamination The experimental FME, transported to the ISS by 
carriers organized by NASA, was unclamped twice by astronauts on the ISS: on day 25 and 50 
after tube sealing, the day of arrival on the ISS and 14 days before the end of its ISS stay, 
respectively. A second, identical experiment was conducted on Earth, as a control. Worms were 
harvested from both systems on day 70 after tube sealing. The space C. elegans spent a total of 
40 days at microgravity. Table 1 shows a complete timeline of the experiment, including changes 
in location, temperature, and state of the FME during its round trip to the ISS and back. 
 
Table 1: Timeline of the Experiment. The letter A stands for arrival (at the ISS) and the 
letter U stands for undock (from the ISS). 
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Location Time 
Start 
Time 
Duration 
Temperature 
(oC) 
Changes made to the FME 
Travel from Toronto 
to Houston (FedEx) 
A-25 
days 
2 days 2-4 None 
NanoRacks (Houston) A-23 
days 
12 days 2-4 None 
Travel from Ferry to 
Launch 
A-11 
days 
11 days 2-4 None 
Rocket travel to ISS A-6 
hours 
6 hours 2-4 None 
ISS A 6 weeks 21-24 A+0 days: Unclamp Clamp A, shake 
gently for 3 seconds 
U-14 days: Unclamp Clamp B, 
shake gently for 3 seconds 
Travel from Landing 
to Houston 
U 4 days 0-10 None 
Travel from Houston 
to Toronto (FedEx) 
U+4 
days 
24 hours 2-4 None 
 
Prior to the launch, we determined the optimal ratio of CeMM to air in each volume of the 
FME for maximum survival of C. elegans.We optimized our ratios by assembling FMEs 
containing variable volumes of CeMM and air and observed the worms to determine which 
conditions maximized survival. We observed the highest number of  live C elegans after 70 days  
using 2.4 mL CeMM/compartment (2.1 worms/L), compared to 2 mL CeMM/compartment (2.5 
worms/L) and  a 2.8 mL CeMM/compartment (1.8 worms/L). Therefore, the optimal ratio of  
2.4 mL of CeMM and 0.4 mL of air was selected, as this ensured that there were live nematodes 
in the FME throughout the ten-week experimental period.  
C. elegans Viability and Morphometric Analyses 
Following return from space, the number of C. elegans in both the experimental and ground 
FMEs were counted. A small equivalent aliquot of worms was taken from each tube, viewed 
with a phase contrast microscope, and photographed. The length and cross-sectional area of live 
C. elegans were measured, using ImageJ software, in 40 randomly chosen individual worms 
from each sample. The average length and area of the worms were then calculated for both the 
space and ground worms. 
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SDS PAGE and ASM Immunoblotting 
To create the C. elegans protein lysate, both tubes of worms were washed three times with 
M9 solution, once with phosphate buffered saline (PBS), and then resuspended in 75 μl of ice-
cold lysis buffer (25 mM Tris [pH 7.4], 100 mM NaCl, 1 mM EDTA, 0.25% NP40, 1 mM 
PMSF, 1 mM Na3VO4, 2.5 mg/mL Pepstatin-A, 10 mM NaF, and 1 Protease Inhibitor Cocktail 
Tablet [Roche, Basil, Switzerland] per 10 mL solution). The samples were incubated on ice for 
30 minutes, then subjected to three cycles of flash freezing in liquid nitrogen, partial thawing, 
and sonication for 5 seconds at 7W. Samples were then incubated at 4oC with agitation for 30 
minutes and centrifuged at 13,000 rpm. Supernatant protein concentration was determined with 
the BCA assay (Thermo Scientific, Waltham MA, USA). 
Worm lysate samples (30μg) were separated by 10% SDS-PAGE, transferred to 
nitrocellulose, Ponceau-S stained and immunoblotted with rabbit anti-acid sphingomyelinase 
antibody (sc-11352 Santa Cruz, CA, USA 1:500 dilution) and detected with IRDye 800 CW 
fluorescent secondary antibody (Mandel Scientific, Guelph ON, Canada ; 1:10,000 dilution). 
Quantification of the Li-Cortm fluorescent signal was performed with the LiCor Odyssey FC 
(Mandel Scientific). Western blotting for GAPDH (ab A245 Abcam, USA; 1:10,000 dilution 
detected with Mandel Scientific IRDye 680 RD, 1:10,000 dilution) was performed as a loading 
control. Samples were run in duplicate. 
Statistical Analysis 
Comparisons between the space worms and control worms were conducted using the 
Student's t-test. Statistical significance was determined if p<0.05. 
RESULTS  
C. elegans Size and Morphometrics 
The space worms were received at the lab 70 days after initial loading into the FME. There 
were 72,050 live space worms, compared to 95,200 live ground worms. The space worms were 
significantly larger in length and in cross-sectional area than the ground worms (Figure 2). The 
mean length of the space worms was 0.42 +/- 0.13 mm, while the ground worms exhibited a 
mean length of 0.29 +/- 0.076 mm. The mean cross-sectional area of the space worms was 
0.0065 +/- 0.0031 mm2, while the mean cross-sectional area of the ground worms was only 
0.0042 +/- 0.0021 mm2. The space worms demonstrated a broader range of distribution of length 
and cross sectional area compared to the control Earth worms (Figure 3).  
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Figure 2: Length and cross-sectional area (CSA) of ground and space worms. 
Representative images of (A) ground worms and (B) space worms are shown Live C. 
elegans appear curled and dead C. elegans assume a straight and thick shape. Only live C. 
elegans were measured. The space worms (N=40) were longer (C), and had larger CSA (D), 
compared to the ground worms (N=40). Data are mean +/- SD. ***p<0.05. 
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Figure 3: Histograms of length and cross-sectional area (CSA) of space and control C. 
elegans. The top panels  depict the distribution of lengths of  randomly selected control C. 
elegans (n=40, left panel) and space C. elegans (n=40, right panel). Bottom panels  similarly 
demonstrate the distribution of CSAs of control (left panel) and space (right panel) worms . 
A broader distribution of both length and CSA is evident in the space worms compared to 
the control Earth worms   
ASM Levels 
The space worms exhibited reduced ASM-1 and ASM-2 expression, compared to the ground 
worms (Figure 4).  
The space worm lysate had a higher protein concentration, compared to the ground worm 
lysate, as determined by a BCA assay (Thermo Scientific). The space worm lysate had a protein 
concentration of 6.667 μg/mL, whereas the ground worm lysate had a protein concentration of 
4.286 μg/mL.  
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Figure 4: Ground and space worm lysates immunoblotted for ASM-1 and ASM-2. The 
space worms exhibited decreased expression of both ASM-1 and ASM-2, compared to the 
ground worms (left panel ASM Western blot, right panel graph of quantified fluorescent 
signal). GAPDH immunostaining demonstrates equivalent protein loading. Data are mean 
+/- SD. ***p<0.05, **p<0.1. 
DISCUSSION 
 
This is, to our knowledge, the first study completed to assess ASM protein expression in C. 
elegans in microgravity. The purpose of the experiment was to gain a better  understanding of 
the molecular regulation of muscle atrophy in microgravity, which may also provide insight into 
the mechanisms of atrophy in disease. We hypothesized that oxidative stress and altered ASM 
expression are involved in the induction of muscle atrophy that results from both sustained 
exposure to microgravity, as is seen in astronauts,  and from ALS. . We predicted that ASM 
levels would be elevated in C. elegans exposed to microgravity, as ASM gene expression levels 
and ceramides have been found to increase in mouse models of ALS (Henriques et al., Cutler et 
al.) We also aimed to test whether the nematodes’ muscle mass would be impacted by the 
microgravity conditions.  
We found the space worms were longer and had greater cross-sectional areas, compared to 
the control Earth worms, with markedly reduced ASM-1 and ASM-2 expression in C. elegans 
exposed to microgravity. These are striking and unanticipated results, contrary to our hypothesis 
and previous literature. Muscle atrophy is observed in humans in spaceflight and previous studies 
have shown similarly that C. elegans in microgravity experience decreased rates of myogenic 
transcription and have lower muscle density (Higashibata et al., 2006). Higashibata (Higashibata 
et al 2016)also reported a decrease in length and fat accumulation in the space flown C. elegans. 
Furthermore, ASM-2 gene expression analyses using cDNA microarrays from ICE-FIRST 
(Selch et al., 2008) and CERISE (Higashitani et al., 2009) showed a 1.3 fold increase, and a 1.1 
fold decrease, respectively,  although these results were not statistically significant (unpublished 
data, personal communication with Nathaniel J. Szewczyk).  
Of interest, Kim and Sun (2012) report that inactivation of the ASM homologs leads to 
slower reproduction and increased longevity of C. elegans. Given the lower expression levels of 
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both ASM-1 and ASM-2 in the space worms, we speculate this may have increased their 
longevity, resulting in an increase in size compared to the Earth worms. Furthermore, slower 
reproduction meant that there were fewer worms in the space tube than in the control tube. As a 
result, each space worm had greater access to nutrients and oxygen, which might also explain 
why the space worms were able to grow larger. The reason for the decrease in ASM levels in 
space worms relative to Earth worms is not known. ASM expression and activity is influenced 
by stress (Chung et al. 2016), and stressors may have impacted the two cohorts of worms 
differentially, but this was not assessed in our study.  
Of interest, we were able to demonstrate that a population of C. elegans can survive for 10 
weeks within the confines of a 17 cm FME; to our knowledge this is a novel finding. A previous 
study completed as part of the SSEP program did not yield live C. elegans upon return to Earth, 
due to an error in feeding the worms during spaceflight. This experiment concluded that the FME 
could not produce viable populations for post-flight analysis on extended missions such as the 
SSEP missions (Warren et al., 2013). With the return of 72,050 live C. elegans from the ISS, our 
study demonstrates that nematode populations can survive with limited oxygen and nutrients for 
at least 70 days. Not only did the worms survive space travel, but the population grew to more 
than fourteen times its original size. Therefore, C. elegans may be used as a model organism for 
future prolonged microgravity experiments. 
There were a number of limitations to our study, as a result of regulations set by NanoRacks, 
NASA, and SpaceX. Only one tube could be sent to space, thereby permitting no experimental 
replicates, which limited the power of our experiment. Although we could not send multiple 
FME tubes to the ISS, we maximized the number of C. elegans within the tube to account for 
variability between worms. Additionally, the experiment needed to be performed in an FME, 
which was difficult to work with. It was prone to leakage, contamination, and overall wear and 
tear. Although preliminary testing conducted by us to optimize experimental conditions allowed 
us to determine the most effective way to seal, subtle leakage or contamination during 
spaceflight could have impacted our results. In order to prevent leakage, two twist ties, gel, and a 
plastic cap were placed on each end of the tube.  however, 1.5mL of liquid was still lost due to 
leakage during the trip. 
There were also several limitations of the experimental design. We did not test for the third 
ASM isoform, ASM-3, which may also affect the lifespan of the nematodes and their oxidative 
stress levels. We did not test for ASM-3 because a commercially produced antibody was not 
available. The anti-ASM antibody used was generated against the human ASM, and while it 
recognized proteins at the correct molecular weight of ASM-1 and ASM-2, it also recognized 
several other bands of unknown significance. These bands may have been due to non-specific 
reactivity or reactivity with degradation products. It is unclear why these bands were only seen in 
the ground control worms, given that GAPDH levels indicated equal loading of ground and 
space worm lysates. Furthermore, we did not evaluate oxidative stress, ASM-1 or 2 activity, or 
evaluate behavioural changes in the worms, which may be influenced by oxidative stress and 
could have served as a surrogate marker (Possik and Pause, 2015). Although this data may have 
enriched our knowledge, we were mainly focused on the impacts of microgravity on ASM 
expression. Lastly, C. elegans size is in part dependent on maturation stage. Notably we did not 
evaluate maturation stage of the space or ground worms, which may have confounded our 
morphometric measurements. 
In summary, as high school students working within the SSEP program, we have importantly 
demonstrated that C. elegans can survive for at least 70 days with limited nutrients, space and 
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oxygen and are therefore a feasible and effective model for spaceflight and for SSEP 
experiments. We also demonstrated a statistically significant difference in expression of ASM 
between ground and space worms, although the underlying mechanisms is not known.. Future 
research should aim to further evaluate the role of ASM in muscle atrophy in both spaceflight 
and in diseases such as ALS, as this may enable the identification of targets and strategies for 
therapeutic manipulation.  
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